Colombia, Think Tank: "Medicines, Information And Power" At Universidad Nacional De Colombia. Centro De Pensamiento, Medicamentos, Información Y Poder. (O.Lizarazo) Opposition, Crystalline Sofosbuvir, + Amorphous Ledipasvir, (Wo2014120981 Pct/Us2014/013953)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
GTPI - Grupo de Trabalho sobre Propriedade Intelectual opposition, Sofosbuvir, (PI0809654-6 - WO2008121634)
Countries: Brazil Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,429,572)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,429,572)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 7,964,580)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,735,372)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,334,270)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,334,270)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 8,633,309)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 9,284,342)
Countries: United States of America Date: 2017
-
Initiative for Medicines, Access & Knowledge (I-Mak) opposition, Sofosbuvir, (US 9,393,256)
Countries: United States of America Date: 2017